ARTICLE | Company News
Vaccine candidate moves forward
February 15, 2000 8:00 AM UTC
BioChem Pharma (BCHE; TSE:BCH) and Biovector Therapeutics (Toulouse, France) will develop a nasal vaccine against Streptococcus pneumoniae using BCHE's protein antigen and Biovector's Light Biovector ...